Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Multiple Myeloma × Neoadjuvant Therapy × Clear all

Phase

Status

Unknown 3 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 Esophageal Squamous Cell Carcinoma 5 Rectal Neoplasms 4 Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Surgery 1 Squamous Cell Carcinoma of External Auditory Canal 1 Recurrence 1 Peritoneal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplastic Cells, Circulating 1 Neoadjuvant Therapy 1 Multiple Myeloma 1 Margins of Excision 1 Malignant Tumor of Lacrimal Drainage Structure 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Locally Advanced Rectal Cancer (LARC) 1

Interventions

Dexamethasone 72 Lenalidomide 44 daratumumab 40 Bortezomib 26 Cyclophosphamide 25 pomalidomide 24 carfilzomib 21 Calcium Dobesilate 20 talquetamab 17 fludarabine 16 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 iberdomide 14 Biopsy 14 isatuximab 13 belantamab mafodotin 12 selinexor 9 elotuzumab 9 dexamethasone acetate 9 dexamethasone 21-phosphate 8 auricularum 8 Melphalan 8 venetoclax 6 X-Rays 6 Blood Specimen Collection 5 tocilizumab 4 pegylated granulocyte colony-stimulating factor 4 ixazomib 4 fludarabine phosphate 4 Nivolumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07149857 2026-03-13

CARTITUDE-10

Janssen Research & Development, LLC

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡